Jorge Aparicio
Hospital Universitario y Politécnico La Fe
Valencia
Spain
Name/email consistency: high
- Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study. Aparicio, J., Maroto, P., del Muro, X.G., Gumà, J., Sánchez-Muñoz, A., Margelí, M., Doménech, M., Bastús, R., Fernández, A., López-Brea, M., Terrassa, J., Meana, A., del Prado, P.M., Sastre, J., Satrústegui, J.J., Gironés, R., Robert, L., Germà, J.R. J. Clin. Oncol. (2011)
- Treatment of stage I testicular germ-cell tumors. Aparicio, J., Germà, J.R. Med. Oncol. (2006)
- First-line treatment with irinotecan and raltitrexed in metastatic colorectal cancer. Mature results of a multicenter phase II study. Aparicio, J., Vicent, J.M., Maestu, I., Bosch, C., Galán, A., Busquier, I., Llorca, C., Garcerá, S., Campos, J.M., López-Tendero, P., Balcells, M. Oncology (2005)
- Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study. Aparicio, J., Germà, J.R., García del Muro, X., Maroto, P., Arranz, J.A., Sáenz, A., Barnadas, A., Dorca, J., Gumà, J., Olmos, D., Bastús, R., Carles, J., Almenar, D., Sánchez, M., Paz-Ares, L., Satrústegui, J.J., Mellado, B., Balil, A., López-Brea, M., Sánchez, A. J. Clin. Oncol. (2005)
- FOLFOX alternated with FOLFIRI as first-line chemotherapy for metastatic colorectal cancer. Aparicio, J., Fernandez-Martos, C., Vincent, J.M., Maestu, I., Llorca, C., Busquier, I., Campos, J.M., Perez-Enguix, D., Balcells, M. Clin. Colorectal. Cancer (2005)
